BCICX | NRIIX | BCICX / NRIIX | |
Total Expense Ratio | 1.57 | 0.91 | 173% |
Annual Report Gross Expense Ratio | 1.69 | 0.93 | 182% |
Fund Existence | 17 years | 14 years | - |
Gain YTD | 4.450 | 6.181 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | 100 | N/A | - |
Net Assets | 10.4B | 1.1B | 945% |
Annual Yield % from dividends | 5.00 | 4.90 | 102% |
Returns for 1 year | 8.00 | 12.58 | 64% |
Returns for 3 years | 21.90 | 20.17 | 109% |
Returns for 5 years | 22.97 | 39.25 | 59% |
Returns for 10 years | 39.33 | 58.04 | 68% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 20.86 | 0.47 | +2.31% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
EFAA | 50.83 | 0.48 | +0.95% |
Invesco MSCI EAFE Income Advantage ETF | |||
DISV | 32.06 | 0.27 | +0.86% |
Dimensional International Sm Cp Val ETF | |||
HGLB | 8.92 | 0.07 | +0.79% |
Highland Global Allocation Fund | |||
AGQ | 47.12 | -0.30 | -0.63% |
ProShares Ultra Silver |